Oral Minoxidil New York Times Coverage: The Impact on Patient Perceptions and Dermatologists’ Approaches to Androgenetic Alopecia
September 2024
in “
Journal of the American Academy of Dermatology
”
Studysummary This study assessed the impact of a New York Times article on consumer interest in androgenetic alopecia treatments by surveying dermatologists about practice trends and analyzing online search data related to low dose oral minoxidil and hair loss from February 2022 to February 2023.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The New York Times article "An Old Medicine Remedies Hair Loss for Pennies a Day" significantly increased public interest in managing Androgenetic Alopecia (AGA) with low dose oral minoxidil (LDOM). This was evidenced by a survey of dermatologists, which showed changes in practice trends, and an analysis of internet search trends using Google Analytics, which revealed heightened searches for terms like LDOM, pattern hair loss (PHL), and AGA over a one-year period from February 2022 to February 2023.
